PGP and neoplasm: Further ixabepilone demonstrated a 6–10 fold higher cancer cell cytotoxicity compared to epothilone B, against a panel of over 20 tumor cell lines which included both drug-sensitive and resistant P-gp overexpressing cancer phenotypes (43, 80).